"Alvine develops treatment for celiac disease, one of the world’s most common autoimmune and inflammation disorders. InterWest’s interest in investing in trailblazing product concepts made it a natural partner. They make sure the team is built right and help them execute the plan we agree on."
LeadershipAbhay Joshi, President & CEO
Alvine Pharmaceuticals is dedicated to developing and commercializing therapeutics for the treatment of celiac sprue, a gluten-induced autoimmune disease for which no drug therapy is currently available. Celiac sprue is believed to affect as many as two million people in the U.S. alone, many of whom have suffered the symptoms of the disease but have not yet been diagnosed.